Gender differences in depression: Implications for treatment

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 15, 1997, Pages 12-18

  Kornstein, Susan G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEPRESSION; DISEASE COURSE; ELECTROCONVULSIVE THERAPY; MENSTRUAL CYCLE; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; PUERPERIUM; RECURRENT DISEASE; REVIEW; SEX DIFFERENCE; TREATMENT PLANNING;

ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; PREVALENCE; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0031473782     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977;34:98-111
2. Weissman MM, Bland R, Joyce PR, et al. Sex differences in rates of depression: cross-national perspectives. J Affect Disord 1993;29:77-84
3. Kessler RC, McGonagle KA, Swartz M, et al. Sex and depression in the National Comorbidity Survey, I: lifetime prevalence, chronicity, and recurrence. J Affect Disord 1993;29:85-96
4. Wolk SI, Weissman MM. Women and depression. In: Annual Review of Psychiatry, vol 14. Washington, DC: American Psychiatric Association; 1995:59-95
5. Blehar MC, Oren DA. Women's vulnerability to mood disorders: integrating psychobiology and epidemiology. Depression 1995;3:3-12
6. Nolen-Hoeksema S. Sex differences in unipolar depression: evidence and theory. Psychol Bull 1987;101:259-282
7. Frank E, Carpenter LL, Kupfer DJ. Sex differences in recurrent depression: are there any that are significant? Am J Psychiatry 1988;145:41-45
8. Young MA, Scheftner WA, Fawcett J, et al. Gender differences in the clinical features of unipolar depressive disorder. J Nerv Ment Dis 1990;178: 200-203
9. Kornstein SG, Schatzberg AF, Yonkers KA, et al. Gender differences in presentation of chronic major depression. Psychopharmacol Bull 1996;31: 711-718
10. Angst J, Dobler-Mikola A. Do the diagnostic criteria determine the sex ratio in depression? J Affect Disord 1984;7:189-198
11. Thase ME, Reynolds CF, Frank E, et al. Do depressed men and women respond similarly to cognitive behavior therapy? Am J Psychiatry 1994;151: 500-505
12. Roy A, Suicide. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry, VI. Baltimore, Md: Williams & Wilkins; 1995:1739-1751
13. Isometsa ET, Henriksson MM, Aro HM, et al. Suicide in major depression. Am J Psychiatry 1994;151:530-536
14. Kessler RC, Brown RL, Broman CL. Sex differences in psychiatric help-seeking: evidence from four large-scale surveys. J Health Soc Behav 1981; 22:49-64
15. Burke KC, Burke JD, Regier DA, et al. Age at onset of selected mental disorders in five community populations. Arch Gen Psychiatry 1990;47: 511-518
16. Fava M, Abraham M, Alpert J, et al. Gender differences in Axis I comorbidity among depressed outpatients. J Affect Disord 1996;38:129-133
17. Sargeant JK, Bruce ML, Florio LP, et al. Factors associated with 1-year outcome of major depression in the community. Arch Gen Psychiatry 1990; 47:519-526
18. Aneshensel CS. The natural history of depressive symptoms. Res Commun Ment Health 1985;5:45-74
19. Ernst C, Angst J. The Zurich study, XII: sex differences in depression: evidence from longitudinal epidemiological data. Eur Arch Psychiatry Clin Neurosci 1992;241:222-230
20. Keitner GI, Ryan CE, Miller IW, et al. 12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression). Am J Psychiatry 1991;148:345-350
21. Winokur G, Coryell W, Keller M, et al. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 1993;50:457-465
22. Bebbington PE, Brugha T, MacCarthy B, et al. The Camberwell Collaborative Depression Study, I: depressed probands: adversity and the form of depression. Br J Psychiatry 1988;152:754-765
23. Karp JF, Frank E. Combination therapy and the depressed woman. Depression 1995;3:91-98
24. Dohrenwend BS. Anticipation and control of stressful life events: an explanatory analysis. Presented at the 47th annual meeting of the Eastern Psychological Association; April 1976; New York, NY
25. Kessler RC, McLeod JD. Sex differences in vulnerability to undesirable life events. Am Soc Rev 1984;49:620-631
26. Gilligan C. In a Different Voice: Psychological Theory and Women's Development. Cambridge, Mass: Harvard University Association; 1982
27. Leibenluft E, Hardin TA, Rosenthal NE. Gender differences in seasonal affective disorder. Depression 1995;3:13-19
28. Parry BL. Reproductive factors affecting the course of affective illness in women. Psychiatr Clin North Am 1989;12:207-220
29. Endicott J. The menstrual cycle and mood disorders. J Affect Disord 1993; 29:193-200
30. Abramowitz ES, Baker AH, Fleischer SF. Onset of depressive psychiatric crises and the menstrual cycle. Am J Psychiatry 1982;139:475-478
31. Kornstein SG, Yonkers KA, Schatzberg AF, et al. Premenstrual exacerbation of depression. Presented at the 148th annual meeting of the American Psychiatric Association; May 20-25, 1995; Miami, Fla
32. Gotlib LA, Whiffen VE, Mount JH, et al. Prevalence and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 1989;57:269-281
33. Stowe ZN, Casarella J, Landry J, et al. Sertraline in the treatment of women with postpartum major depression. Depression 1995;3:49-55
34. Frank E, Kupfer DJ, Jacob M, et al. Pregnancy-related affective episodes among women with recurrent depression. Am J Psychiatry 1987;144: 288-293
35. Garvey MJ, Tuason VB, Lumry AE, et al. Occurrence of depression in the postpartum state. J Affect Disord 1983;5:97-101
36. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Second Edition. Washington, DC: American Psychiatric Association; 1968:36
37. Schmidt PJ, Rubinow DR. Menopause-related affective disorders: a justification for further study. Am J Psychiatry 1991;148:844-852
38. Griffin S. Menopause and mood. Depression 1995;3:56-59
39. Stewart DE, Boydell KM. Psychologic distress during menopause: associations across the reproductive cycle. Int J Psychiatry Med 1993;23:157-162
40. Slap GB. Oral contraceptives and depression: impact, prevalence, and cause. J Adolesc Health 1981;2:53-64
41. Wagner KD, Berenson AB. Norplant-associated major depression and panic disorder. J Clin Psychiatry 1994;55:478-480
42. Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1995: 2338-2340
43. Magos AL, Brewster E, Singh R, et al. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 1986;93:1290-1296
44. Blazer DG, Kessler RC, McGonagle KA, et al. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994;151:979-986
45. Regier DA, Burke JD, Burke KC. Comorbidity of affective and anxiety disorders in the NIMH Epidemiologic Catchment Area Program. In: Maser JD, Cloninger CR, eds. Comorbidity of Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press; 1990:113-122
46. Judd LL. When anxiety disorders are comorbid with major depression: social and clinical burden. Presented at the 147th annual meeting of the American Psychiatric Association: May 21-26, 1994; Philadelphia, Pa
47. Williams JBW, Spitzer RL. The issue of sex bias in DSM-III. Am Psychol 1983;38:793-798
48. Merikangas KR, Leckman JF, Prusoff BA, et al. Familial transmission of depression and alcoholism. Arch Gen Psychiatry 1985;42:367-372
49. Reus VI. Behavioral aspects of thyroid disease in women. Psychiatr Clin North Am 1989;12:153-165
50. Whybrow PC. Sex differences in thyroid axis dysfunction: relevance to affective disorder and its treatment. Depression 1995;3:33-42
51. Moldin SO, Scheftner WA, Rice JP, et al. Association between major depressive disorder and physical illness. Psychol Med 1993;23:755-761
52. Shea MT, Glass DR, Pilkonis PA, et al. Frequency and implications of personality disorders in a sample of depressed outpatients. J Pers Disord 1987; 1:27-42
53. Golomb M, Fava M, Abraham M, et al. Gender differences in personality disorders. Am J Psychiatry 1995;152:579-582
54. Dawkins K, Potter WZ. Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on women. Psychopharmacol Bull 1991;27:417-426
55. Yonkers KA, Hamilton J. Psychotropic medications. In: Annual Review of Psychiatry, vol 14. Washington, DC: American Psychiatric Press; 1995: 59-95
56. Yonkers KA, Kando JC, Cole JO, et al. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 1992;149:587-595
57. Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender, and Hormones. Washington, DC: American Psychiatric Press; 1996
58. Moody JP, Tait AC, Todrick A. Plasma levels of imipramine and desmethylimipramine during therapy. Br J Psychiatry 1967;113:183-193
59. Hamilton JA, Grant M, Jensvold MF. Sex and treatment of depressions: when does it matter? In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender, and Hormones. Washington, DC: American Psychiatric Press; 1996:241-257
60. Preskom SH, Mac DS. Plasma levels of amitriptyline: effects of age and sex. J Clin Psychiatry 1985;46:276-277
61. Gex-Fabry M, Balant-Gorgia AE, Balant LP, et al. Clomipramine metabolism: model-based analysis of variability factors from drug monitoring data. Clin Pharmacokinet 1990;19:241-255
62. Greenblatt DJ, Friedman H, Burstein ES, et al. Trazodone kinetics: effect of age, gender, and obesity. Clin Pharmacol Ther 1987;42:193-200
63. Warrington SJ. Clinical implications of the pharmacology of sertraline. Int Clin Psychopharmacol 1991;6:11-21
64. Abernethy DR, Greenblatt DJ, Shader RI. Imipramine disposition in users of oral contraceptives. Clin Pharmacol Ther 1984;35:792-797
65. Gram LF, Christiansen J. First-pass metabolism of imipramine in man. Clin Pharmacol Ther 1975;17:555-563
66. Kimmel S, Gonsalves L, Youngs D, et al. Fluctuating levels of antidepressants. J Psychosom Obstet Gynaecol 1992;13:277-280
67. Jensvold MF, Reed K, Jarrett DB, et al. Menstrual cycle-related depressive symptoms treated with variable antidepressant dosage. Journal of Women's Health 1992;1:109-115
68. Wisner KL, Perel JM, Wheeler SB. Tricyclic dose requirements across pregnancy. Am J Psychiatry 1993;150:1541-1542
69. Old Age Depression Interest Group. How long should the elderly take antidepressants? a double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Br J Psychiatry 1993;162:175-182
70. Raskin A. Age-sex differences in response to antidepressant drugs. J Nerv Ment Dis 1974;159:120-130
71. Glassman AH, Perel JM, Shostak M, et al. Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry 1977;34: 197-204
72. Coppen A, Whybrow P, Noguera R, et al. The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiatry 1972;26:234-241
73. Davidson J, Pelton S. Forms of atypical depression and their response to antidepressant drugs. Psychiatry Res 1986;17:87-95
74. Steiner M, Wheadon DE, Kreider MS, et al. Antidepressant response to paroxetine by gender. Presented at the 146th annual meeting of the American Psychiatric Association; May 22-27, 1993; San Francisco, Calif
75. Prange AJ, Wilson IC, Rabon AM, et al. Enhancement of imipramine antidepressant activity by thyroid hormone. Am J Psychiatry 1969;126: 457-469
76. Gorman JM, Hatterer JA. The role of thyroid hormone in refractory depression. In: Nolen WA, Zohar J, Roose SP, et al, eds. Refractory Depression: Current Strategies and Future Directions. West Sussex, England: John Wiley & Sons; 1994:121-128
77. Whybrow PC. Sex differences in thyroid axis dysfunction: relevance to affective disorder and its treatment. Depression 1995;3:33-42
78. Klaiber EL, Broverman DM, Vogel W, et al. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979;36:550-554
79. Holsboer F, Benkert O, Demisch L. Changes in MAO activity during estrogen treatment of females with endogenous depression. Mod Probl Pharmacopsychiatry 1983;19:321-326
80. Shapira B, Oppenheim G, Zohar J, et al. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psychiatry 1985;20:576-579
81. Oppenheim G. Estrogen in the treatment of depression: neuropharmacological mechanisms. Biol Psychiatry 1983;18:721-725
82. Prange AJ. Estrogen may well affect response to antidepressant. JAMA 1972;219:143-144
83. Kindler S, Sasson Y, Cohen R, et al. The role of oestrogen augmentation in females with refractory depression. In: Nolen WA, Zohar J, Roose SP, et al. eds. Refractory Depression: Current Strategies and Future Directions. West Sussex. England: John Wiley & Sons; 1994:155-158
84. Sherwin BB. Estrogen and refractory depression. Advances in Neuropsychiatry and Psychopharmacology 1991;2:209-218
85. Schneider L. Issues specific to depression in older women: does estrogen affect antidepressant response? Presented at the 148th annual meeting of the American Psychiatric Association; May 20-25, 1995; Miami, Fla
86. Jarrett RB, Eaves GG, Grannemann BD, et al. Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Psychiatry Res 1991;37:245-260
87. Lawson JS. Gender issues in electroconvulsive therapy. Psych Ann 1996; 26:717-720
88. Sackeim HA, Decina P, Prohovnik I, et al. Seizure threshold in electroconvulsive therapy: effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry 1987;44:355-360
89. Coffey CE, Lucke J, Weiner RD, et al. Seizure threshold in electroconvulsive therapy, I: initial seizure threshold. Biol Psychiatry 1995;37:713-720
90. McCall W, Shelp FE, Weiner RD, et al. Convulsant threshold differences in right unilateral and bilateral ECT. Biol Psychiatry 1993;34:606-611
91. Sackeim HA, Portnoy S, Neeley P, et al. Cognitive consequences of low-dosage electroconvulsive therapy. Ann NY Acad Sci 1986;462:326-340